President, The Endeavor Group. Waldman has been in the press a lot of late; most recently it has been reported in The Guardian that Waldman visited Julian Assange nine times in 2017. Adam R. Waldman, J.D. is a Co-Founder of The Endeavor Group, Inc and also serves as its Chairman of the Board and President. Mr. Waldman is responsible for all aspects of private equity investment, portfolio company management, asset acquisition and sale, and large-scale project execution on behalf of Endeavor's clients at Endeavor. Mr. Waldman acts in several capacities on behalf of Endeavor clients. Mr. Waldman has extensive experience as a legal and business advisor to individuals, corporations and government. From 1999 to 2001, Mr. Waldman served as the Senior Telecommunications Counsel to Assistant Attorney General Joel Klein at the U.S. Department of Justice. He was responsible for overseeing DOJ's investigation of proposed merger transactions in the telecommunications sector and on the corporate aspects of the Government's proposed breakup of the Microsoft Corporation. Prior to his government service, Mr. Waldman was a corporate lawyer and mergers & acquisitions specialist in the Washington, D.C. law firm of Wilmer, Cutler & Pickering, where he facilitated domestic and international corporate transactions. He serves as a Director of Dyad Pharmaceutical Corporation, Indian River Brewing Company, i5 Investments, founding Board Member of Friends of the Global Fight and the Center for Global Development (CGD). He also serves on the Board of Directors of several privately held companies in which clients hold significant equity interests, providing a wide range of management, legal and investment services representing client interests. He served as a Director of Altor BioScience Corporation until March 16, 2016. Mr. Waldman received his Juris Doctorate from the American University Law School and received a Bachelor of Arts degree from Rollins College.